MENU
TNYA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tenaya Therapeutics (TNYA) Ownership - Who owns Tenaya Therapeutics?
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease... Show more
Profile
Industry
N/A
Address
171 Oyster Point Boulevard
Phone
+1 650 825-6990
Employees
140
Web
https://www.tenayatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
88.02M
P/E Ratio
N/A
Total Cash
88.16M
Projected Growth
N/A
Total Debt
12.91M
Revenue
N/A
Risk (Beta)
3.10
Dividend Yield
N/A
Total Cash/Share
0.54
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TNYA
Capitalization
88M
P/E Ratio
N/A
Risk (Beta)
3.10
Dividend Yield
N/A
Total Cash
88.2M
Total Cash/Share
0.54
Total Debt
12.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
119M
P/B Ratio
0.74
Cash Flow
N/A
Earnings
-1.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
6.68
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-100.75M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-64.32
Shares Held By Institutions
107M
Shares Outstanding - Current
163M
Total Liabilities
24.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-62.161
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
171 Oyster Point Boulevard
Phone
+1 650 825-6990
Employees
140
Web
https://www.tenayatherapeutics.com